148 related articles for article (PubMed ID: 20953613)
1. Plaque regression in one artery is not necessarily associated with parallel changes in other vascular beds.
Suzuki T; Nozawa T; Fujii N; Sobajima M; Ohori T; Shida T; Matsuki A; Kameyama T; Inoue H
Heart Vessels; 2011 May; 26(3):242-51. PubMed ID: 20953613
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy of candesartan with statin inhibits progression of atherosclerosis more than statin alone in patients with coronary artery disease.
Suzuki T; Nozawa T; Fujii N; Sobajima M; Ohori T; Shida T; Matsuki A; Kameyama T; Inoue H
Coron Artery Dis; 2011 Aug; 22(5):352-8. PubMed ID: 21494127
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effect of statin is continuously working throughout use: a prospective three time point
Kang MK; Kim CJ; Choo EH; Han EJ; Hwang BH; Kim JJ; Kim SH; O JH; Chang K
Int J Cardiovasc Imaging; 2019 Sep; 35(9):1745-1753. PubMed ID: 31312997
[TBL] [Abstract][Full Text] [Related]
4. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI.
Yonemura A; Momiyama Y; Fayad ZA; Ayaori M; Ohmori R; Kihara T; Tanaka N; Nakaya K; Ogura M; Taniguchi H; Kusuhara M; Nagata M; Nakamura H; Tamai S; Ohsuzu F
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):222-8. PubMed ID: 19242355
[TBL] [Abstract][Full Text] [Related]
5. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial.
Emami H; Vucic E; Subramanian S; Abdelbaky A; Fayad ZA; Du S; Roth E; Ballantyne CM; Mohler ER; Farkouh ME; Kim J; Farmer M; Li L; Ehlgen A; Langenickel TH; Velasquez L; Hayes W; Tawakol A
Atherosclerosis; 2015 Jun; 240(2):490-6. PubMed ID: 25913664
[TBL] [Abstract][Full Text] [Related]
6. The LDL-cholesterol to HDL-cholesterol ratio and the severity of coronary and aortic atherosclerosis.
Momiyama Y; Ohmori R; Fayad ZA; Tanaka N; Kato R; Taniguchi H; Nagata M; Ohsuzu F
Atherosclerosis; 2012 Jun; 222(2):577-80. PubMed ID: 22516791
[No Abstract] [Full Text] [Related]
7. Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.
Koskinas KC; Zaugg S; Yamaji K; García-García HM; Taniwaki M; Klingenberg R; Moschovitis A; Lüscher TF; van Tits LJ; Matter CM; Windecker S; Räber L
Atherosclerosis; 2016 Apr; 247():154-60. PubMed ID: 26921743
[TBL] [Abstract][Full Text] [Related]
8. Correlation between plaque vulnerability of aorta and coronary artery: an evaluation of plaque activity by direct visualization with angioscopy.
Aono J; Ikeda S; Katsumata Y; Higashi H; Ohshima K; Ishibashi K; Matsuoka H; Watanabe K; Hamada M
Int J Cardiovasc Imaging; 2015 Aug; 31(6):1107-14. PubMed ID: 25916323
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Atherosclerotic Calcification in Major Vessel Beds on the Risk of All-Cause and Cause-Specific Mortality: The Rotterdam Study.
Bos D; Leening MJ; Kavousi M; Hofman A; Franco OH; van der Lugt A; Vernooij MW; Ikram MA
Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659376
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study.
Fernández-Friera L; Peñalvo JL; Fernández-Ortiz A; Ibañez B; López-Melgar B; Laclaustra M; Oliva B; Mocoroa A; Mendiguren J; Martínez de Vega V; García L; Molina J; Sánchez-González J; Guzmán G; Alonso-Farto JC; Guallar E; Civeira F; Sillesen H; Pocock S; Ordovás JM; Sanz G; Jiménez-Borreguero LJ; Fuster V
Circulation; 2015 Jun; 131(24):2104-13. PubMed ID: 25882487
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of plaque echolucency in combination with inflammatory biomarkers on cardiovascular outcomes of coronary artery disease patients receiving optimal medical therapy.
Ishizu T; Seo Y; Machino T; Kawamura R; Kimura T; Murakoshi N; Sato A; Takeyasu N; Watanabe S; Aonuma K
Atherosclerosis; 2011 May; 216(1):120-4. PubMed ID: 21353222
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of carotid atheroma assessed by quantitative ultrasound analysis in nonhypercholesterolemic patients with coronary artery disease.
Watanabe K; Sugiyama S; Kugiyama K; Honda O; Fukushima H; Koga H; Horibata Y; Hirai T; Sakamoto T; Yoshimura M; Yamashita Y; Ogawa H
J Am Coll Cardiol; 2005 Dec; 46(11):2022-30. PubMed ID: 16325036
[TBL] [Abstract][Full Text] [Related]
13. Plasma fibronectin level and its association with coronary artery disease and carotid intima-media thickness.
Orem C; Durmuş I; Kilinç K; Baykan M; Gökçe M; Orem A; Topbaş M
Coron Artery Dis; 2003 May; 14(3):219-24. PubMed ID: 12702925
[TBL] [Abstract][Full Text] [Related]
14. [Relation of the thickness of the intima and media of the common carotid artery, atherosclerotic plaque in the carotids and manifestations of atherosclerosis in the vessels of the lower extremity in comparison to coronary atherosclerosis].
Holaj R; Spácil J; Petrásek J; Malík J; Aschermann M; Haas T
Cas Lek Cesk; 1998 Nov; 137(23):716-20. PubMed ID: 9990175
[TBL] [Abstract][Full Text] [Related]
15. microRNA-155 Is Decreased During Atherosclerosis Regression and Is Increased in Urinary Extracellular Vesicles During Atherosclerosis Progression.
Fitzsimons S; Oggero S; Bruen R; McCarthy C; Strowitzki MJ; Mahon NG; Ryan N; Brennan EP; Barry M; Perretti M; Belton O
Front Immunol; 2020; 11():576516. PubMed ID: 33391256
[TBL] [Abstract][Full Text] [Related]
16. [The role of ultrasonography of the peripheral arteries in diagnosing coronary artery disease].
Pasierski T; Sosnowski C; Szulczyk A; Leszczyński L; Rewicki M
Pol Arch Med Wewn; 2004 Jan; 111(1):21-5. PubMed ID: 15088417
[TBL] [Abstract][Full Text] [Related]
17. Impact of Intensive LDL Cholesterol Lowering on Coronary Artery Atherosclerosis Progression: A Serial CT Angiography Study.
Shin S; Park HB; Chang HJ; Arsanjani R; Min JK; Kim YJ; Lee BK; Choi JH; Hong GR; Chung N
JACC Cardiovasc Imaging; 2017 Apr; 10(4):437-446. PubMed ID: 27771404
[TBL] [Abstract][Full Text] [Related]
18. Specific Lp(a) apheresis: A tool to prove lipoprotein(a) atherogenicity.
Pokrovsky SN; Afanasieva OI; Safarova MS; Balakhonova TV; Matchin YG; Adamova IYU; Konovalov GA; Ezhov MV
Atheroscler Suppl; 2017 Nov; 30():166-173. PubMed ID: 29096833
[TBL] [Abstract][Full Text] [Related]
19. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.
Hibi K; Kimura T; Kimura K; Morimoto T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
Atherosclerosis; 2011 Dec; 219(2):743-9. PubMed ID: 21899843
[TBL] [Abstract][Full Text] [Related]
20. Relation between the incidence, location, and extent of thoracic aortic atherosclerosis detected by transesophageal echocardiography and the extent of coronary artery disease by angiography.
Gu X; He Y; Li Z; Kontos MC; Paulsen WH; Arrowood JA; Vetrovec GW; Nixon JV
Am J Cardiol; 2011 Jan; 107(2):175-8. PubMed ID: 21129720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
